On March 28, the FDA approved Imfinzi for use in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by single-agent Imfinzi as adjuvant treatment after radical cystectomy, ...

Hims, Keeps and other companies advertise topical finasteride with limited disclosures of side effects.

Many compounding pharmacies are no longer allowed to make cheaper versions of semaglutide and other GLP-1 drugs. A doctor ...

BofA notes that the Food and Drug Administration issued an alert on the potential risks associated with compounded topical finasteride products ...

The Food and Drug Administration (FDA) announced actions Tuesday to phase out the use of petroleum-based food dyes in U.S.

Hims & Hers Health (HIMS) stock declined about 2% yesterday. The fall came after the U.S. Food and Drug Administration (FDA) ...